A Placebo-Controlled Crossover Study of Iloperidone Augmentation of SSRIs for Residual Anger and Irritability in Major Depressive Disorder
Phase of Trial: Phase IV
Latest Information Update: 14 Apr 2017
At a glance
- Drugs Iloperidone (Primary)
- Indications Anger; Irritability; Major depressive disorder
- Focus Therapeutic Use
- 14 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Nov 2014 Planned End Date changed from 1 Apr 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov..
- 22 Feb 2013 Planned End Date changed from 1 Oct 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.